期刊文献+

深圳市第二人民医院就诊甲状腺癌患者发病相关因素研究 被引量:2

Study On the Risk Factors of Thyroid Cancer Among Patients of the Second People's Hospital of Shenzhen
下载PDF
导出
摘要 目的调查深圳市第二人民医院就诊的甲状腺癌患者的患病特点,分析并找出与甲状腺癌发病率相关的潜在危险因子。明确甲状腺癌与碘营养之间的相关性,为合理的碘摄入以及甲状腺癌的防治工作提供科学依据。方法采取连续收录与分层抽样的方法,收集2013年2月至2014年12月于深圳市第二人民医院核医学科甲状腺病门诊就诊的甲状腺癌患者123例,结节性甲状腺肿组患者150例及正常对照组102例;测定尿碘含量;采集血样检测甲状腺功能;并完成相关的情绪压力、焦虑及生活方式等问卷调查。结果患者婚姻状态、教育程度、居住地区、情绪焦虑评分、T4、TSH 6个变量有统计学意义(P<0.05),提示这6个变量可能与甲状腺癌患病相关;患者血脂高(高脂血症)、BMI体重指数与甲癌可能有相关,相关性接近有统计学差异;而患者尿碘浓度与甲癌患病显示无显著相关性(P=1.65)。结论本研究中收录的患者甲状腺癌的发生率与尿碘水平无明显相关性;而与患者肥胖、婚姻状况等生活方式因素以及情绪焦虑相关。 Objective In the last few decades, the incidence of thyroid cancer has been found rapidly increased worldwide as well as in China. It is suspected that this increasing might be related to the iodine over-intake since the introduction of USI. However, the results were of inconsistence, and we aim to look into this relationship in Shenzhen. Methods A total of 123 patients with diagnosis of thyroid cancer (TC) and 150 patients with nodular goiter were consecutively recruited while 102 normal subjects were randomly selected as control group in comparing the urine Iodine levels. The thyroid hormones, thyroid autoantibodies in serum were also measured. Life-style and social economic factors were collected. Anxiety and stress were scored by questionnaires and compared among the three groups. Results There was no significant difference between the TC group, nodular goiter group and control group in terms of urine iodine levels ( 120.2 ± 118.9μg/L, 128.5 ± 136μg/L vs. 124.5 ± 124μg/L;F = 0. 32, P = 0. 572). Multiple regression analysis indicated that the thyroid cancer incidence was significantly associated with patient' s marital status, education levels, higher BMI ( P 〈 0.05 ) and anxiety scores. Conclusion Incidence of thyroid cancer is not significant associated with patient' s urine Iodine level but associated with the life-style factors such as obesity, divorce, education and anxiety.
出处 《标记免疫分析与临床》 CAS 2015年第5期424-427,共4页 Labeled Immunoassays and Clinical Medicine
基金 深圳市科技创新委员会(JC201105170709A)
关键词 甲状腺癌 碘营养 尿碘中位数 Thyroid cancer Iodine nutrition MUI
  • 相关文献

参考文献13

  • 1郑荣寿,张思维,吴良有,李光琳,赵平,赫捷,陈万青.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12. 被引量:560
  • 2杨雷,郑荣寿,王宁,张思维,陈万青.2010年中国甲状腺癌发病与死亡情况[J].中华预防医学杂志,2014,48(8):663-668. 被引量:106
  • 3Xie S H, Chen J, Zhang B, et al. Time trends and age-period- cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong. BMC Cancer, 2014 ,14:975.
  • 4Wang Y, Wang W. Increasing Incidence of Thyroid Cancer in Shanghai, China, 1983-2007. Asia Pac J Public Health,2015 ,27 (2) : 223-229.
  • 5郑平,郑军,刘列钧.国标法与快速法测定尿碘的对比实验[J].中国地方病学杂志,2000,19(3):216-217. 被引量:2
  • 6张兴全,郭三巧,李森,等.快速测定法与国标法分析尿液碘结果对比.中华医学会地方病学分会第6次全国地方病学术会议论文集,2007,26:413-416.
  • 7Marcello M A, Cunha L L, Batista F A, et al. Obesity and thyroid cancer. Endocr Relat Cancer,2014,21 (5) :255-271.
  • 8HanJM, Kim T Y, Jeon M J, et al. Obesity is a risk factor mr thyroid cancer in a large, uhrasonographically screened population. Eur J Endocrinol, 2013,168 (6) :879-886.
  • 9Haymart M R, Glinberg S L, Liu J,et al. Higher serum TSH in tyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol(Oxf) , 2009,71 (3) :434- 439.
  • 10闫慧娴,谷伟军,吕朝晖.血清促甲状腺激素与甲状腺癌的关系[J].国际内分泌代谢杂志,2013,33(5):318-320. 被引量:15

二级参考文献83

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2欧维新,袁薇锦.基于景观连接度的盐城滨海湿地丹顶鹤生境斑块重要性评价[J].资源科学,2015,37(4):823-831. 被引量:21
  • 3朱强,俞孔坚,李迪华.景观规划中的生态廊道宽度[J].生态学报,2005,25(9):2406-2412. 被引量:535
  • 4吝涛,薛雄志,卢昌义,洪华生.厦门国家级自然保护区白鹭生态安全评价[J].生态学报,2006,26(12):3998-4006. 被引量:17
  • 5陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 6Jonklaas J, Sarlis NJ, Litofsky D, et al.Outcomes of patients with differentiated thyroid carcinoma following initial therapy [J]. Thyroid, 2006,16( 12):1229-1242.
  • 7McGriff NJ, Csako G, Gourgiotis L, et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer[J]. Ann Med, 2002,34(7-8 ):554-564.
  • 8Biondi B, Filetti S, Schlumberger M.Thyroid-hormone therapy and thyroid cancer: a reassessment[J]. Nat Clin Prac,2005,1 (1):32-40.
  • 9张木勋,昊亚群.甲状腺疾病诊断学[M].北京:中国医药科技出版社,2005:9-134.
  • 10Hovens GC, Stokkel MP, Kievit J, et al.Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer[J]. Clin Endocrinol Metab ,2007,92(2 ) :2610-2615.

共引文献692

同被引文献20

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部